Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2026-01-31 @ 3:48 AM
Study NCT ID:
NCT06757634
Status:
RECRUITING
Last Update Posted:
2025-06-18
First Post:
2024-12-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Sponsor:
Organization: